Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Binovi Technologies's 3-Year RORE % for the quarter that ended in Feb. 2022 was 0.00%.
The industry rank for Binovi Technologies's 3-Year RORE % or its related term are showing as below:
BNVIF's 3-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.195 * Ranked among companies with meaningful 3-Year RORE % only.
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Binovi Technologies 3-Year RORE % Related Terms
Binovi Technologies 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Binovi Technologies's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BNVIF vs CERN, VEEV, CHNG: 3-Year RORE % Comparison
For the Health Information Services subindustry, Binovi Technologies's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binovi Technologies 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Binovi Technologies's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Binovi Technologies's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Feb. 2022 and 3-year before.
Binovi Technologies (BNVIF) has a 3-Year RORE % of 0.00 as of Feb. 2022. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Binovi Technologies and its competitors.
Is Binovi Technologies' 3-Year RORE % too high?
Binovi Technologies' current 3-Year RORE % is 0.00. Overall, Binovi Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Binovi Technologies' 3-Year RORE % compare to CERN and VEEV?
Binovi Technologies' 3-Year RORE % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year RORE % is 0.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Binovi Technologies and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binovi Technologies's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binovi Technologies stock overvalued right now?
Binovi Technologies (BNVIF) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Binovi Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Binovi Technologies (BNVIF), the current 3-Year RORE % is 0.00 as of Feb. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Binovi Technologies Corp is engaged in the development and commercialization of visual and neuro-cognitive processing products and manufacturing hardware and software for diagnosing and remediating visual perception disorders. The company has three geographical segments; the United States, Canada, and Other. it derives a majority of its revenue from the United States.
10GF Score
Get the complete analysis for BNVIF
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BNVIF has been successfully added to your 
